Stock de sistemas delcath
10/18/2019 · NEW YORK, Oct 18, 2019 (GLOBE NEWSWIRE via COMTEX) -- Delcath Systems, Inc. (otcqb:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company's Board of Directors has authorized a reverse stock split of the Company's common stock at a ratio of 1-for-100. Real-time trade and investing ideas on Delcath Systems, Inc. DCTH from the largest community of traders and investors. Rooms Trade App. ©2019 StockTwits, Inc. Delcath Systems, Inc. stock quote and DCTH charts. Latest stock price today and the US's most active stock market forums. 9/6/2017 · Delcath CEO Dr. Jennifer Simpson has once again written a letter to shareholders asking for a vote in favor of a reverse split. The company has yet to announce the split ratio (could range from 1-for-20 to 1-for-500). The deadline for voting is September 6, 2017, before 11:59 p.m. EST.
12/13/2019 · The following slide deck was published by Delcath Systems, Inc. in conjunction with this event. Download PDF 119 Click to enlarge Notes
Delcath Systems, Inc. chart and DCTH price. Free real-time prices, trades and chat. Delcath Systems, Inc. (DCTH) stock price, charts, trades & the US's most popular discussion forums. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Reddit is not like StockTwits. When submitting a post here, try to make sure it is informative and/or will possibly result in a discussion. Questions are allowed, but please make sure you have at least done a google search beforehand. Stock charts are allowed, but make sure you describe it. Are you researching Delcath Systems (OTCMKTS:DCTH) stock for your portfolio? View DCTH's latest 10K form and other filings with the Securities and Exchange Commission Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company’s Board of Directors has authorized a reverse stock split of the Company’s common stock at a ratio of 1-for-100. Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Reverse Stock Split reported on October 21, 2019 will be postponed per a subsequent notification received from FINRA after-market that they have decided to continue their review.
Delcath Systems (DCTH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Site uses Cookies This website utilizes cookies and similar technologies for functionality and other purposes including personalization of content.
Delcath Systems Stock Price Forecast, DCTH stock price prediction. Price target in 14 days: 54.906 USD. The best long-term & short-term Delcath Systems share price Delcath Systems Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Delcath are investigating the potential for our therapy in two key areas: 1. FOCUS 301A Registration study—for patients with ocular melanoma metastatic to the liver. Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan Hydrochloride for Injection, which is a proprietary product used with the Delcath Hepatic Delivery System. Delcath expressly disclaims any obligation to review, update or correct these materials after the date thereof. Delcath may update, amend, supplement or otherwise alter the information contained in any such materials by subsequent presentations, reports, filings, or other means without notice. delcath systems stock to take or not to take? Stock like roulette – today green, tomorrow red. You can seriously increase your capital after a while or, conversely, after a while your capital may decline. Terms of investing in delcath systems stock.
delcath systems stock to take or not to take? Stock like roulette – today green, tomorrow red. You can seriously increase your capital after a while or, conversely, after a while your capital may decline. Terms of investing in delcath systems stock.
: Get the latest Delcath Systems stock price and detailed information including news, historical charts and realtime prices. 4/10/2014 · S hares of Delcath Systems, Inc. ( DCTH) tanked nearly 20% to $3.73 following its 1-to-16 reverse stock split, which came into effect yesterday. According to an SEC filing, the stock split trimmed Delcath shares to roughly 9.4 million from 150.9 million.
Delcath Systems (DCTH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Site uses Cookies This website utilizes cookies and similar technologies for functionality and other purposes including personalization of content.
Delcath Systems, Inc. Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body.
Delcath expressly disclaims any obligation to review, update or correct these materials after the date thereof. Delcath may update, amend, supplement or otherwise alter the information contained in any such materials by subsequent presentations, reports, filings, or other means without notice. delcath systems stock to take or not to take? Stock like roulette – today green, tomorrow red. You can seriously increase your capital after a while or, conversely, after a while your capital may decline. Terms of investing in delcath systems stock. Delcath Systems (DCTH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Site uses Cookies This website utilizes cookies and similar technologies for functionality and other purposes including personalization of content. : Get the latest Delcath Systems stock price and detailed information including news, historical charts and realtime prices. 4/10/2014 · S hares of Delcath Systems, Inc. ( DCTH) tanked nearly 20% to $3.73 following its 1-to-16 reverse stock split, which came into effect yesterday. According to an SEC filing, the stock split trimmed Delcath shares to roughly 9.4 million from 150.9 million.